🇺🇸 FDA
Patent

US 11077117

Pharmaceutical compositions comprising meloxicam

granted A61KA61K31/4196A61K31/5415

Quick answer

US patent 11077117 (Pharmaceutical compositions comprising meloxicam) held by AXSOME THERAPEUTICS, INC. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/4196, A61K31/5415, A61K47/02, A61K47/40